Can Metabolic Associated Steatotic Liver Disease (MASLD) be fully cured?

Metabolic Associated Steatotic Liver Disease (MASLD), formerly known as Non-Alcoholic Fatty Liver Disease (NAFLD), is a condition characterized by the accumulation of excess fat in the liver. Although there is no "total cure" in the traditional sense, implying the permanent disappearance of the disease without any intervention, the condition is highly reversible and can be significantly improved, or even lead to the resolution of damage in many cases, especially in the early stages. This depends largely on the patient's commitment to lifestyle changes and appropriate treatment.

MASLD is a common chronic disease often associated with other health conditions such as obesity, type 2 diabetes, high cholesterol or triglycerides, and high blood pressure. The primary goal of treatment is to reduce fat accumulation in the liver and prevent the progression of the disease to more serious stages, such as Metabolic Dysfunction-Associated Steatohepatitis (MASH), which can lead to liver fibrosis or even liver cancer [1].

The Role of Weight Loss and Lifestyle Modification

Weight loss is the first and most important step in treating MASLD. Weight loss can reduce liver fat, alleviate inflammation, and even improve fibrosis. There are currently no medications approved to treat MASLD directly, making lifestyle modifications the cornerstone of effective disease management [1].

• Healthy Diet: It is recommended to follow a healthy diet that limits salt and sugar, and focuses on consuming plenty of fruits, vegetables, and whole grains. This can help reduce the fat accumulated in the liver [1].
• Regular Physical Activity: Exercising regularly not only helps with weight loss but also contributes to reducing liver fat and improving overall health [1].
• Avoiding Certain Medications: If a healthcare provider suspects that a specific medication is the cause of MASLD, they may recommend stopping or changing it. However, you should not stop taking any medication without consulting your doctor [1].

The Difference Between MASLD and MASH

It is important to understand the difference between MASLD and its more advanced form, Metabolic Dysfunction-Associated Steatohepatitis (MASH). While MASLD refers to the presence of fat in the liver with little or no inflammation or damage, MASH involves inflammation and liver damage in addition to fat. MASH can lead to liver fibrosis, which is scarring of the liver, and may eventually progress to cirrhosis or liver cancer [1].

Controlling MASLD in its early stages prevents its progression to MASH, thereby reducing the risk of serious complications. Periodic check-ups and monitoring of liver function can help track the disease's progression [1]. To learn more about tests, you can visit Metabolic Associated Steatotic Liver Disease: Tests, Fibrosis, and Weight (Arabic).

Potential Complications and When to Seek Emergency Care

In most cases, MASLD does not cause clear symptoms. If symptoms occur, they may include fatigue or discomfort in the upper right abdomen [1]. However, if the disease progresses to cirrhosis, more serious symptoms may appear, such as jaundice (yellowing of the skin and whites of the eyes), swelling in the legs and abdomen, internal bleeding, and mental confusion [2].

If any of these severe symptoms occur, immediate medical attention must be sought. Although these symptoms usually do not occur in the early stages of MASLD, they indicate a significant deterioration in liver function and require urgent medical intervention.

Next Steps and Medical Follow-up

Because MASLD is often asymptomatic, a healthcare provider may suspect its presence based on abnormal results in routine liver tests [1]. Early diagnosis and regular follow-up with a doctor are crucial for effectively managing the condition.

It is essential to consult a doctor before using any dietary supplements or herbal remedies, as some may harm the liver [1]. A doctor can provide personalized guidance based on your overall health, and may recommend certain vaccines, such as those for hepatitis A and B, influenza, and pneumococcal disease, as people with chronic liver disease are more susceptible to infections [1].

Medical references

• Steatotic Liver Disease
• Cryptogenic cirrhosis